Breaking News Instant updates and real-time market news.

IVC

Invacare

$5.34

0.12 (2.30%)

, SNBR

Sleep Number

$35.88

0.39 (1.10%)

19:04
02/13/19
02/13
19:04
02/13/19
19:04

Fly Intel: After Hours Movers

UP AFTER EARNINGS: Invacare (IVC) up 2.2%... Sleep Number (SNBR) up 11.8%... Yelp (YELP) up 5.7%... Cisco (CSCO) up 3.8%... Vanda Pharma (VNDA) up 3.7%... Diodes (DIOD) up 3.5%... Antero Resources (AR) up 3.1%. DOWN AFTER EARNINGS: Sierra Wireless (SWIR) down 22.6%... Fossil Group (FOSL) down 16.0%... Brookdale Senior Living (BKD) down 13.8%... Rayonier Advanced Materials (RYAM) down 11.0%... CenturyLink (CTL) down 10.6%... NetApp (NTAP) down 6.5%... Brightcove (BCOV) down 5.8%... Tanger Factory Outlet Center (SKT) down 5.5%... i3 Verticals (IIIV) down 5.0%... Laredo Petroleum (LPI) down 4.8%... ASGN Inc (ASGN) down 4.3%... AIG (AIG) down 3.0%... MGM Resorts (MGM) down 2.8%... Nu Skin Enterprises (NUS) down 2.2%... Williams Companies (WMB) down 2.0%... PluralSight (PS) down 1.9%... SurveyMonkey (SVMK) down 1.5%... Hyatt (H) down 1.2%.

IVC

Invacare

$5.34

0.12 (2.30%)

SNBR

Sleep Number

$35.88

0.39 (1.10%)

YELP

Yelp

$38.46

-0.46 (-1.18%)

CSCO

Cisco

$47.48

-0.39 (-0.81%)

VNDA

Vanda Pharmaceuticals

$18.43

0.03 (0.16%)

DIOD

Diodes

$37.35

1.04 (2.86%)

AR

Antero Resources

$9.08

-0.18 (-1.94%)

SWIR

Sierra Wireless

$15.51

-0.19 (-1.21%)

FOSL

Fossil

$15.77

-0.45 (-2.77%)

BKD

Brookdale Senior Living

$8.11

0.12 (1.50%)

RYAM

Rayonier Advanced Materials

$14.98

0.36 (2.46%)

CTL

CenturyLink

$14.70

0.15 (1.03%)

NTAP

NetApp

$67.22

0.09 (0.13%)

BCOV

Brightcove

$8.59

-0.11 (-1.26%)

SKT

Tanger Factory

$22.23

-0.11 (-0.49%)

IIIV

i3 Verticals

$25.26

0.74 (3.02%)

LPI

Laredo Petroleum

$3.79

0.155 (4.27%)

ASGN

ASGN

$66.79

1.84 (2.83%)

AIG

AIG

$44.18

0.38 (0.87%)

MGM

MGM Resorts

$29.23

0.37 (1.28%)

NUS

Nu Skin

$69.58

0.985 (1.44%)

WMB

Williams

$27.02

0.28 (1.05%)

PS

Pluralsight

$31.59

-0.29 (-0.91%)

SVMK

SurveyMonkey

$14.04

-0.05 (-0.35%)

H

Hyatt

$73.44

3.14 (4.47%)

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 04

    Mar

  • 05

    Mar

  • 06

    Mar

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

  • 14

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

  • 16

    Aug

IVC Invacare
$5.34

0.12 (2.30%)

08/16/18
08/16/18
DOWNGRADE

Sector Weight
Invacare downgraded to Sector Weight after Q2 results at KeyBanc
As previously reported, KeyBanc analyst Matthew Mishan downgraded Invacare to Sector Weight from Overweight post Q2. The analyst believes its turnaround is not progressing as quickly as he hoped and rather than seeing some acceleration toward long-term targets, Mishan is again resetting his expectations lower. While stable with some positives, there are still headwinds constraining broader sales momentum, the analyst notes, adding that he is surprised there has not been more upside to margins given both restructuring activity and mix shift.
01/24/19
NEED
01/24/19
INITIATION
Target $15
NEED
Buy
Invacare initiated with a Buy at Needham
Needham analyst Mike Matson initiated Invacare with a Buy rating and a price target of $15, saying the company's global business is "growing and profitable", even though North America operations have suffered from "myriad of challenges". The analyst believes that the stock is trading as a "distressed asset due to its recent history of declining revenue and negative margins", but contends that over 80% of the company is "healthy", expecting its management to "stabilize its revenue, margins, and cash flow".
08/15/18
KEYB
08/15/18
DOWNGRADE
KEYB
Sector Weight
Invacare downgraded to Sector Weight from Overweight at KeyBanc
05/02/18
UBSW
05/02/18
UPGRADE
UBSW
Neutral
Invacare upgraded to Neutral from Sell at UBS
UBS analyst Tim Plumbe upgraded Invacare to Neutral from Sell citing valuation but remains cautious on market share losses and declining EBITDA due to closures.
SNBR Sleep Number
$35.88

0.39 (1.10%)

09/19/18
WEDB
09/19/18
NO CHANGE
Target $65
WEDB
Outperform
Antidumping petition could lead to relief for mattress cos, says Wedbush
A consortium of U.S. mattress manufacturers yesterday filed an antidumping duty petition with the U.S. Department of Commerce and the U.S. ITC against foam and innerspring mattresses imported from China. In a research note to investors, Wedbush analyst Seth Basham says antidumping duties over 200% could "tip the scales" back in favor of U.S. producers of low-end U.S. mattresses like Tempur Sealy's (TPX) Sealy, but says the impact for Sleep Number (SNBR) is "more limited" with no exposure to the low-mattress segment, and that Purple (PRPL) could benefit "modestly." The analyst believes that more important for Tempur Sealy is the fate of Mattress Firm (MFRM), the largest U.S. mattress retailer, which he continues to expect to file near-term for bankruptcy.
07/26/18
PIPR
07/26/18
DOWNGRADE
Target $33
PIPR
Neutral
Sleep Number downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Peter Keith downgraded Sleep Number to Neutral and lowered his price target for the shares to $33 from $41. The Q2 earnings report was "inline with consensus but relatively disappointing," Keith tells investors in a research note. Despite a product line refresh, sales trends remain "surprisingly sluggish," the analyst contends. He believes this could be the result of escalating competition from low-price import mattresses and that his dynamic is "unlikely to change in any notable fashion."
01/28/19
LEHM
01/28/19
INITIATION
Target $36
LEHM
Equal Weight
Sleep Number initiated with an Equal Weight at Barclays
Barclays analyst Matthew McClintock started Sleep Number with an Equal Weight rating and $36 price target. The company does not have the same easy comparisons as Tempur Sealy (TPX) and is further along in gaining the benefit of its direct-to-consumer expansion, McClintock tells investors in a research note.
07/10/18
WEDB
07/10/18
NO CHANGE
Target $65
WEDB
Outperform
Mattress sales 'soft,' Tempur Sealy likely below consensus for Q2, says Wedbush
Following checks with retailers across the U.S., Wedbush analyst Seth Basham told investors in a research note that nationwide brick-and-mortar retail mattress sales declined in the low-single digits in the second quarter, and though sales grew early in the quarter, they declined in May and June. Based on his checks, Basham says 4th of July period sales declined low-single digits to mid-single digits for B&M retailers, driven by steepening traffic declines and ASP gains, and that Tempur Sealy (TPX) specifically is likely to be below consensus for the quarter, with sales trends weakening due to elevated cannibalization rates as customers traded down to new, lower-priced products. He believes Tempur Sealy will maintain at least the low end of of its 2018 EBITDA guidance of $450M-$500M. Additionally, Basham says Sleep Number (SNBR) may be "slightly light" of consensus for the quarter, as his checks show that sales trends remained muted for the 4th of July period. The analyst has an Outperform rating and $65 price target on Tempur Sealy and a Neutral rating and $34 price target on Sleep Number.
YELP Yelp
$38.46

-0.46 (-1.18%)

01/10/19
MSCO
01/10/19
DOWNGRADE
Target $29
MSCO
Underweight
Morgan Stanley sees revenue headwinds for Yelp, downgrades to Underweight
As previously reported, Morgan Stanley analyst Brian Nowak downgraded Yelp (YELP) to Underweight from Equal Weight as he identified three building revenue headwinds that he believes will lead to negative revisions and underperformance of the stock. First, Nowak sees the increased flexibility of Yelp's new non-term agreements leading to lower spend per customer. Second, he sees pricing compression risk given that his ad pricing analysis shows Yelp's average cost per click is still over four times higher than Google (GOOGL) and Facebook (FB). Third, he expects Yelp's declining user base to further hold back spend per customer. Nowak cut his price target on Yelp shares to $29 from $31, noting that his revised FY19 and FY20 EBITDA estimates are now 2% and 6%, respectively, below consensus.
02/04/19
GSCO
02/04/19
INITIATION
Target $42
GSCO
Buy
Yelp initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Michael Ng started Yelp with Buy rating and $42 price target. Yelp's transition to non-term advertising contracts should increase trial activity and drive growth in paid advertising accounts, Ng tells investors in a research note. He also believes the company should more effectively gain market share from other forms of direct advertising, particularly as U.S. advertising spending on directories is "nearly depleted." Further, new product features, such as a Request a Quote in home services and Nowait & Reservations in restaurants, should help Yelp accelerate revenue growth in those verticals, says the analyst.
01/10/19
01/10/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lockheed Martin (LMT) downgraded to Equal Weight from Overweight at Morgan Stanley. 2. JetBlue (JBLU) downgraded to Neutral from Overweight at JPMorgan with analyst Jamie Baker lowering his price target for the shares to $18 from $20. 3. Weatherford (WFT) downgraded to Market Perform from Outperform at BMO Capital with analyst Daniel Boyd saying the stock represents a "call-option on the oil cycle," but sees that option "suffering from time decay" and an adverse macro environment. 4. Yelp (YELP) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Brian Nowak saying he identified three building revenue headwinds that he believes will lead to negative revisions and underperformance of the stock. 5. Dollar Tree (DLTR) downgraded to Perform from Outperform at Oppenheimer with analyst Rupesh Parikh saying he now views shares as fully valued and sees the case for upside as less attractive. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/04/19
02/04/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Yelp (YELP) initiated with a Buy at Goldman Sachs while Groupon (GRPN) was initiated with a Neutral, and Match Group (MTCH) and Shutterfly (SFLY) were initiated with a Sell. 2. eHealth (EHTH) initiated with an Outperform at Evercore ISI. 3. Okta (OKTA) initiated with an Equal Weight at Morgan Stanley. 4. Lonestar Resources (LONE) initiated with an Outperform at Cowen. 5. Kopin (KOPN) initiated with a Buy at Ladenburg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
CSCO Cisco
$47.48

-0.39 (-0.81%)

02/12/19
MSCO
02/12/19
DOWNGRADE
Target $49
MSCO
Equal Weight
Cisco downgraded to Equal Weight at Morgan Stanley as security growth slows
As previously reported, Morgan Stanley analyst James Faucette downgraded Cisco Systems to Equal Weight from Overweight, noting that Cisco's multiple has meaningfully expanded over the past 1.5 years as estimates and expectations have built in a likely benefit from security-driven networking. While he thinks the company is making steady progress towards a security-defined networking business model, his latest surveys suggest the pipeline for Cisco's Security sales is flattening, which Faucette believes is partly due to slowing improvements in its security portfolio, the analyst tells investors. Additionally, his industry talks in late January and early February suggest the government shutdown is having a follow through effect, which is slowing the normal seasonal improvement of the April quarter, Faucette added. He lowered his price target for Cisco shares to $49 from $51.
02/12/19
MSCO
02/12/19
DOWNGRADE
Target $49
MSCO
Equal Weight
Cisco downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst James Faucette downgraded Cisco Systems to Equal Weight and lowered his price target for the shares to $49 from $51.
02/12/19
02/12/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. BHP Billiton (BHP) downgraded to Neutral from Buy at Goldman Sachs. 2. Gilead (GILD) downgraded to Neutral from Buy at Citi and to Market Perform from Outperform at Wells Fargo. 3. Cisco (CSCO) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst James Faucette saying Cisco's multiple has meaningfully expanded over the past 1.5 years as estimates and expectations have built in a likely benefit from security-driven networking. 4. Take-Two (TTWO) downgraded to Underperform from Market Perform at BMO Capital with analyst Gerrick Johnson saying that after a 2-year "hype machine" blast for its Red Dead Redemption 2 title and its "strong" premier, the buzz around the game has "dissipated markedly." 5. Fastenal (FAST) downgraded to Sector Weight from Overweight at KeyBanc with analyst Steve Barger saying he continues to view the company as a "best-in-class" distributor with a "sizable first-mover advantage" in OnSite and Vending, but he finds the stock's risk/reward as more balanced near his prior price target of $62. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/18/19
JPMS
01/18/19
NO CHANGE
JPMS
JPMorgan buyers of Cisco, Sensata, Arista Networks into Q4 results
JPMorgan analyst Samik Chatterjee previews the Q4 earnings reports in Networking Equipment and says his firm is a buyer of Cisco Systems (CSCO), Sensata (ST), and Arista Networks (ANET) into the prints. Relative to the rest of his coverage, the analyst sees greater headwinds on the horizon for Corning (GLW) in 2019 than is being appreciated by investors. As such, he would be cautious on Corning shares going into its Q4 earnings report.
VNDA Vanda Pharmaceuticals
$18.43

0.03 (0.16%)

02/06/19
02/06/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. PayPal (PYPL) downgraded to Neutral from Buy at Guggenheim with the firm citing balanced risk/reward. 2. Arlo Technologies (ARLO) downgraded to Underperform from Neutral at BofA/Merrill and to Market Perform from Outperform at Cowen. 3. Celanese (CE) downgraded to Market Perform from Outperform at Cowen with analyst Charles Neivert saying recent subtle changes in industry fundamentals and the macro outlook have made him more cautious. 4. Estee Lauder (EL) downgraded to Hold from Buy at Berenberg with analyst Rosie Edwards saying that while the company's Q2 results were "strong across the board," she expects top-line growth to moderate, due mainly to skincare and Asia-Pacific. 5. Vanda Pharmaceuticals (VNDA) downgraded to Neutral from Overweight at Cantor Fitzgerald with analyst Charles Duncan saying the company's complaint against the FDA reduces visibility on development timelines for tradipitant in gastroparesis, perhaps even pruritus, and may also affect Hetlioz label expansion efforts. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/06/19
CANT
02/06/19
DOWNGRADE
CANT
Neutral
Vanda Pharmaceuticals downgraded to Neutral from Overweight at Cantor Fitzgerald
02/06/19
CANT
02/06/19
DOWNGRADE
Target $30
CANT
Neutral
Cantor downgrades Vanda on reduced visibility after FDA complaint
Cantor Fitzgerald analyst Charles Duncan downgraded Vanda Pharmaceuticals to Neutral from Overweight and lowered his price target for the shares to $30 from $38. The company's complaint against the FDA reduces visibility on development timelines for tradipitant in gastroparesis, perhaps even pruritus, and may also affect Hetlioz label expansion efforts, Duncan tells investors in a research note. The "challenged" FDA interactions are a result of management disagreement with the agency over the scientific merits of conducting certain nonclinical testing, says the analyst.
12/11/18
12/11/18
DOWNGRADE

Perform
Vanda downgraded to Perform at Oppenheimer on balanced risk/reward
As previously reported, Oppenheimer analyst Esther Rajavelu downgraded Vanda Pharmaceuticals to Perform from Outperform saying that with the tasimelteon Smith-Magenis Syndrome trial meeting one of the two primary endpoints, the stock fairly reflects the inherent risk/reward at current trading levels. The analyst will await on the sidelines the publication of the results and an update on the regulatory strategy post the pre-NDA meeting.
DIOD Diodes
$37.35

1.04 (2.86%)

06/07/18
SIDC
06/07/18
DOWNGRADE
SIDC
Neutral
Diodes downgraded to Neutral from Buy at Sidoti
04/19/18
04/19/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Walmart (WMT) upgraded to Buy from Hold at Argus with analyst Christopher Graja saying he believes an improving job market should help low-and-middle-income shoppers spend more. 2. Sprint (S) upgraded to Neutral from Underperform at Macquarie. 3. iRobot (IRBT) upgraded to Overweight from Neutral at Piper Jaffray with analyst Troy Jensen saying tracking data shows iRobot is experiencing "exceptionally strong demand in North America." 4. Diodes (DIOD) upgraded to Buy from Neutral at Longbow with analyst Shawn Harrison saying he expects rising demand, pricing, and Pericom growth to drive sales, gross margins, and earnings higher. 5. Texas Capital (TCBI) upgraded to Overweight from Neutral at Piper Jaffray with analyst Brett Rabatin saying he sees Texas Capital outperforming peers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/07/18
BNCH
11/07/18
NO CHANGE
Target $45
BNCH
Buy
Diodes results, guidance 'much better' than feared, says Benchmark
Benchmark analyst Gary Mobley reiterated his Buy rating on Diodes (DIOD) shares after the company's Q3 results and Q4 guidance were both "much better" than feared at a time when peers such as Texas Instruments (TXN) are "struggling." He maintains a $45 price target on Diodes, stating that he believes the company can take market share in 2018.
09/19/18
SIDC
09/19/18
UPGRADE
SIDC
Buy
Diodes upgraded to Buy from Neutral at Sidoti
AR Antero Resources
$9.08

-0.18 (-1.94%)

12/19/18
RAJA
12/19/18
DOWNGRADE
RAJA
Underperform
Antero Resources downgraded to Underperform at Raymond James
12/05/18
MKMP
12/05/18
INITIATION
Target $17
MKMP
Buy
Antero Resources initiated with a Buy at MKM Partners
MKM Partners analyst John Gerdes started Antero Resources with a Buy rating and $17 price target.
09/21/18
09/21/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Bluebird Bio (BLUE) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Salveen Richter saying rating change is is not driven by concerns around Bluebird's pipeline execution or emerging competitive threats. The analyst just believes appreciation of key aspects of his investment thesis are better reflected in the shares at current valuation levels. 2. Venator Materials (VNTR) downgraded to Neutral from Overweight at JPMorgan with analyst Jeffrey Zekauskas saying he believes lower prices and higher raw material costs for TiO2, coupled with higher capital expenditures, diminishes Venator's free cash flow outlook. 3. Antero Resources (AR) downgraded to Market Perform from Outperform at BMO Capital with analyst Phillip Jungwirth citing valuation. 4. New Age Beverages (NBEV) downgraded to Hold from Buy at Maxim. 5. Rowan Companies (RDC) downgraded to Hold from Buy at HSBC. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/20/18
SOCO
12/20/18
DOWNGRADE
SOCO
Equalweight
Antero Resources downgraded to Equalweight from Overweight at Capital One
SWIR Sierra Wireless
$15.51

-0.19 (-1.21%)

08/03/18
ROTH
08/03/18
NO CHANGE
Target $23
ROTH
Buy
Sierra Wireless outlook and buyback should ease concerns, says Roth Capital
Roth Capital analyst Scott Searle said that Sierra Wireless' "beat and raise" quarterly report and announcement of a buyback authorization should alleviate concerns. The analyst, who sees the company being well positioned for the "coming wave of connected devices" given its new product cycles and general IoT and cloud strength, raised his estimates for Sierra Wireless and increased his price target on the stock to $23 from $22 and keeps a Buy rating on the share.
11/09/18
ADAM
11/09/18
NO CHANGE
Target $32
ADAM
Buy
Sierra Wireless price target raised to $32 from $28 at Canaccord
Canaccord analyst T. Michael Walkley raised his price target on Sierra Wireless to $32 from $28 following strong Q3 results. The analyst believes its device-to-cloud strategy will start generating improving margins with cross-selling opportunities driving strong long-term EBITDA growth. Walkley reiterated his Buy rating on Sierra Wireless shares.
11/09/18
CIBC
11/09/18
DOWNGRADE
Target $19
CIBC
Underperformer
Sierra Wireless downgraded to Underperformer from Neutral at CIBC
CIBC analyst Todd Coupland downgraded Sierra Wireless to Underperformer from Neutral and lowered his price target on the shares to $19 from $20 after the company issued disappointing Q4 guidance due to slowing growth and U.S. tariffs on Chinese imports. He lowered his 2019 sales growth estimate for Sierra Wireless to 9% and sees the company having limited operating leverage, Coupland noted.
11/09/18
FANA
11/09/18
DOWNGRADE
Target $25
FANA
Outperform
Sierra Wireless downgraded to Outperform from Strong Buy at First Analysis
First Analysis analyst Howard Smith downgraded Sierra Wireless to Outperform and lowered his price target for the shares to $25 from $31. The analyst says that while Sierra's "solid" position in the growing Internet of Things market and prospects for better margins long term will reward shareholders, he's feeling "less certain about near-term progress toward its goals amid near-term pressures on revenue and margin." The company's guidance for Q4 was below expectations even when backing out tariff impacts on the bottom line, Smith tells investors in a post-earnings research note.
FOSL Fossil
$15.77

-0.45 (-2.77%)

06/04/18
KEYB
06/04/18
NO CHANGE
Target $32
KEYB
Overweight
Fossil price target raised to $32 from $25 at KeyBanc
KeyBanc analyst Edward Yruma raised his price target for Fossil to $32 from $25 has he believes the company has turned the corner - a combination of expense reductions, focus on wearables, and a more favorable secular watch environment. Further, the analyst argues that new fashion trends and millennial interest in watches seems to be driving a stabilized watch environment. Yruma reiterates an Overweight rating on the shares.
07/10/18
07/10/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Spotify (SPOT) initiated with a Perform at Oppenheimer. 2. CME Group (CME) initiated with a Neutral at Compass Point. 3. Weight Watchers (WTW) initiated with an Overweight at KeyBanc. 4. Fossil (FOSL) initiated with an Overweight at KeyBanc. 5. Alvarion (ALVR) initiated with a Neutral at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/09/18
KEYB
07/09/18
INITIATION
KEYB
Overweight
Fossil initiated with an Overweight at KeyBanc
07/12/18
KEYB
07/12/18
NO CHANGE
Target $32
KEYB
Overweight
KeyBanc sees concerns on Fossil tariff exposure as 'compelling opportunity'
KeyBanc analyst Edward Yruma thinks that concerns on Fossil's tariff exposure present a "compelling near-term trading opportunity." After reviewing the USTR-2018-0026, the most recent list of $200B in annual trade goods subject to a potential 10% ad valorem duty, the analyst has concluded that wrist watches are not included and believes concerns are overdone. Yruma reiterates an Overweight rating and $32 price target on the shares.
BKD Brookdale Senior Living
$8.11

0.12 (1.50%)

10/11/18
SPHN
10/11/18
NO CHANGE
SPHN
Stephens says home health final rule looking like draft would weigh on providers
Stephens analyst Dana Hambly said he expects the final rule for home health reimbursement to be released by CMS in the first week of November. He is concerned that if the final rule looks similar to the draft rule, particularly regarding behavioral assumptions, it would weigh on home health stocks. For-profit, urban providers with higher percentages of therapy visits are estimated to take the largest cuts under a Patient Driven Groupings Model for reimbursement, said Hambly, who sees the impact being largest for Brookdale Senior Living (BKD) and Humana's (HUM) Kindred at Home. Others that may be impacted include Amedisys (AMED), Encompass Health (EHC), Ensign Group (ENSG) and LHC Group (LHCG).
04/30/18
BMOC
04/30/18
UPGRADE
Target $53
BMOC
Market Perform
Ventas upgraded to Market Perform at BMO Capital on valuation
As reported earlier, BMO Capital John Kim upgraded Ventas (VTR) to Market Perform from Underperform and raised his price target to $53 from $51. Kim cites a more attractive valuation after the stock price came down another 19% in 2018. The analyst also notes that the extension of Ventas' master lease with Brookdale (BKD) "addresses a major 2019 expiration" and buys time to deal with non-performing assets while also reducing the possibility of a dividend cut in the short term.
06/27/18
MUFG
06/27/18
NO CHANGE
Target $62
MUFG
Overweight
Welltower price target raised to $62 from $58 at MUFG
MUFG analyst Karin Ford raised her price target on Welltower (WELL) to $62 and kept her Outperform rating, citing the company's progress in restructuring over half of the assisted and independent living portfolio operated by Brookdale Senior Living (BKD). The analyst claims that Welltower achieved favorable pricing on its purchases and sales in the transition, adding that she is positive on the company generating $91M in cash while reducing its exposure to a "troubled operator".
12/27/18
12/27/18
NO CHANGE

Stephens to keep GrubHub, RealPage, Vulcan Materials on 2019 Best Ideas list
Stephens said that it plans to publish a complete updated 2019 Best Ideas list on January 2, but in anticipation it shared the names that are being dropped and the three stocks that will remain on the list. The holdovers are GrubHub (GRUB), RealPage (RP) and Vulcan Materials (VMC). The stocks being removed include Boston Scientific (BSX), Brookdale Senior Living (BKD), Conn's (CONN), CoStar Group (CSGP), Curo Group (CURO), FedEx (FDX), First Financial Bancorp (FFBC), Graphic Packaging (GPK), Hub Group (HUBG), Keane Group (FRAC), KeyCorp (KEY), LKQ Corp. (LKQ), Myriad Genetics (MYGN), SVB Financial (SIVB), Triumph Bancorp (TBK), TrueCar (TRUE) and Union Bankshares (UBSH).
RYAM Rayonier Advanced Materials
$14.98

0.36 (2.46%)

03/27/18
BOFA
03/27/18
NO CHANGE
BOFA
Ciena, Rayonier Advanced Materials added to Endeavor list at BofA/Merrill
BofA/Merrill portfolio strategist Derek Harris removed DST Systems (DST) and Camping World (CWH) from the firm's Endeavor list, which selects approximately 15 to 25 small cap stocks the firm views as most compelling using a multi-disciplinary process. Ciena (CIEN) was added to the list, with Harris noting a continued upcycle in spending on 100-gigabit optical equipment and upside on data center interconnect growth as potential catalysts. Rayonier Advanced Materials (RYAM) was also added to the list, with the recent acquisition of Tembec cited as potentially accretive to EPS and free cash flow.
07/12/18
BREN
07/12/18
INITIATION
Target $25
BREN
Buy
Rayonier Advanced Materials initiated with a Buy at Berenberg
Berenberg analyst Paretosh Misra initiated Rayonier Advanced Materials with a Buy and $25 price target given expectations for a rebound in EBITDA per tonne in the core cellulose business, overly bearish expectations on self-help initiatives and M&A synergies, and possible accelerated stock buybacks.
07/12/18
07/12/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Galmed (GLMD) initiated with an Overweight at Cantor Fitzgerald. 2. VF Corp. (VFC) initiated with a Buy at Deutsche Bank. 3. NetApp (NTAP) initiated with a Buy at Guggenheim. 4. Rayonier Advanced Materials (RYAM) initiated with a Buy at Berenberg. 5. Ebix (EBIX) initiated with a Buy at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/09/18
VERT
05/09/18
UPGRADE
VERT
Buy
Rayonier Advanced Materials upgraded to Buy from Hold at Vertical Research
CTL CenturyLink
$14.70

0.15 (1.03%)

02/05/19
SBSH
02/05/19
DOWNGRADE
Target $11
SBSH
Sell
Citi sees 50% dividend cut for CenturyLink in 2020, downgrades to Sell
Citi analyst Michael Rollins downgraded CenturyLink to Sell from Neutral and cut his price target for the shares to $11 from $19. The analyst expects headwinds on revenue and cash flow, a possible dividend cut, and the likelihood for capex upgrades to lead to further multiple contraction. CenturyLink will face a "growing tug of war" on cash flow beginning in 2019, which will result in a dividend payout level "well above its previously articulated comfort zone," Rollins tells investors in a research note. The analyst forecasts a 50% dividend cut in 2020 for CenturyLink. Further, he believes a sum-of-parts approach "is not compelling" given that the heritage CenturyLink operations are experiencing mid-single digit revenue declines and Level 3 hasn't grown revenue over the last two years.
02/05/19
02/05/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Rent-A-Center (RCII) downgraded to Neutral from Buy at Janney Montgomery Scott with analyst John Rowan citing the stock's 50% rise from its intra-day low of $11.98 on December 18, 2018. 2. Equifax (EFX) downgraded to Hold from Buy at Deutsche Bank with analyst Ashish Sabadra saying the shares have rallied significantly off the bottom and outperformed the market year-to-date due to expectations for improving mortgage originations and overall consumer lending. 3. Kraft Heinz (KHC) downgraded to Hold from Buy at Deutsche Bank with analyst Rob Dickerson saying his analysis shows store brands continue to increase distribution points and take share in the majority of Kraft Heinz's largest categories. 4. CenturyLink (CTL) downgraded to Sell from Neutral at Citi with analyst Michael Rollins saying he expects headwinds on revenue and cash flow, a possible dividend cut, and the likelihood for capex upgrades to lead to further multiple contraction. 5. Cronos Group (CRON) downgraded to Hold from Buy at GMP Securities with analyst Martin Landry citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/05/19
SBSH
02/05/19
DOWNGRADE
SBSH
Sell
CenturyLink downgraded to Sell from Neutral at Citi
Citi analyst Michael Rollins downgraded CenturyLink to Sell.
01/29/19
JPMS
01/29/19
NO CHANGE
Target $38
JPMS
Overweight
CenturyLink deal for Zayo Group could be difficult, says JPMorgan
JPMorgan analyst Philip Cusick says within the potential reported bidders for Zayo Group (ZAYO), he remains "somewhat skeptical" of a strategic transaction by a customer. He sees many of the customers as either not really needing to own the asset or not wanting to own parts of the assets. However, a deal with CenturyLink (CTL) could make strategic sense, says Cusick, who models $280M of annual synergies in his base case. The analyst, though, feels CenturyLink acquiring Zayo could be difficult given CenturyLink's "stretched balance sheet and very expensive cost of equity." Regardless of a potential deal, Cusick continues to recommend Zayo shares with an Overweight rating and $38 target, mostly based on fundamental improvements from here with the potential for a "faster return through M&A."
NTAP NetApp
$67.22

0.09 (0.13%)

02/08/19
OTRG
02/08/19
DOWNGRADE
OTRG
Mixed
NetApp downgraded to Mixed from Positive at OTR Global
01/16/19
01/16/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Citi (C) downgraded to Hold from Buy at Standpoint Research. 2. Snap (SNAP) downgraded to Sector Perform from Outperform at RBC Capital with analyst Mark Mahaney citing the company's recent "mixed" pre-announcement and, more importantly, its latest disclosure of a "surprise" exit by its CFO Tim Stone who was on the job for less than a year. 3. Nordstrom (JWN) downgraded to Neutral from Conviction Buy at Goldman Sachs, to Neutral from Overweight at Atlantic Equities, and to Market Perform from Outperform at Telsey Advisory. 4. AB InBev (BUD) downgraded to Underperform from Hold at Jefferies with analyst Edward Mundy saying market share pressures, some of which have only recently become visible, will likely persist, and could lead to disappointment against high expectations of an emerging-led recovery. 5. HP Enterprise (HPE) downgraded to Equal Weight from Overweight at Morgan Stanley, while NetApp (NTAP) was downgraded to Underweight from Equal Weight. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/11/19
PIPR
02/11/19
NO CHANGE
PIPR
Piper storage survey positive for Pure Storage, Nutanix, NetApp
Piper Jaffray conducted its fiscal Q4 Storage Reseller Survey by collecting feedback from 28 resellers and distributors. While only five of 14 vendors had net positive results versus six of the 14 last quarter, the firm saw "strong results" for Pure Storage (PSTG), Rubrik, Nutanix (NTNX), Veeam and NetApp (NTAP), analyst Andrew Nowinski told investors earlier in a research note. Pure Storage also had the strongest pipeline heading into the April quarter, added the analyst. The company's results sharply improved in the survey, with 67% of resellers citing "Above Plan" results, the highest level seen in three years, says Nowinski. The stock in early trading is up 19c to $18.47. Of those surveyed by Piper, 36% of resellers said they saw a negative impact from the U.S. government shutdown, with Dell (DELL), HP/3PAR (HPQ) and IBM (IMB) the most impacted.
01/16/19
01/16/19
NO CHANGE

Morgan Stanley downgrades IT Hardware industry view, shakes up ratings
Morgan Stanley analyst Kathryn Huberty downgraded her IT Hardware industry view to In-Line from Attractive, noting that hardware spending plans downticked more than any other technology category and across U.S. and European CIOs in the firm's recent checks. Slowing growth, which she attributes to waning cyclical benefits, makes it more difficult to own hardware-heavy data center stocks in the near-term, Huberty tells investors. As previously reported, Huberty downgraded HP Enterprise (HPE) to Equal Weight from Overweight and lowered her price target to $15 from $21, telling investors she thinks it's prudent to take a more cautious near-term stance given that 57% of its revenue comes from Servers and Storage. Huberty also downgraded NetApp (NTAP) to Underweight from Equal Weight and lowered her price target to $58 from $72, citing her view that revenue growth is likely to slow materially on more difficult compares in the coming quarters. Stating that she has a preference for hardware stocks with a higher software mix, Huberty upgraded Nutanix (NTNX) to Overweight and raised her price target to $58 from $57. Nutanix is gaining momentum as a hybrid cloud operating system provider as it adds cloud services, she tells investors. Huberty also upgraded Teradata (TDC) to Overweight from Equal Weight and raised her price target to $55 from $42. Teradata's relevance to large enterprise IT spending is on the rise with Data Warehousing and analytics rising to a top three priority in 2019, she stated.
BCOV Brightcove
$8.59

-0.11 (-1.26%)

12/11/18
RILY
12/11/18
UPGRADE
Target $12
RILY
Buy
Brightcove upgraded to Buy from Neutral at B. Riley FBR
B. Riley FBR analyst Sameet Sinha upgraded Brightcove to Buy and raised his price target for the shares to $12 from $7.
12/11/18
RILY
12/11/18
UPGRADE
Target $12
RILY
Buy
B. Riley FBR upgrades Brightcove to Buy, boosts target to $12 from $7
B. Riley FBR analyst Sameet Sinha upgraded Brightcove to Buy from Neutral and raised his price target for the shares to $12 from $7. The company's restructuring and strategy overhaul position it for double digit revenue growth, in line with the newly identified $1.6B video total addressable market, Sinha tells investors in a research note. Further, he believes Brightcove's competitive environment is easing as competition appears to be focusing on adjacent markets and customers.
SKT Tanger Factory
$22.23

-0.11 (-0.49%)

10/16/18
SCOT
10/16/18
INITIATION
Target $21
SCOT
Underperform
Tanger Factory initiated with an Underperform at Scotiabank
Scotiabank analyst Nicholas Yulico initiated Tanger Factory with an Underperform and $21 price target.
12/19/18
JPMS
12/19/18
DOWNGRADE
Target $22
JPMS
Underweight
Tanger Factory downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Anthony Paolone downgraded Tanger Factory to Underweight and lowered his price target for the shares to $22 from $24. The downgrade is primarily driven by an improved outlook/preference for other property types in the REIT space, says the analyst.
05/02/18
KEYB
05/02/18
DOWNGRADE
KEYB
Underweight
Tanger Factory downgraded to Underweight from Sector Weight at KeyBanc
05/02/18
05/02/18
DOWNGRADE
Target $19

Underweight
Tanger Factory downgraded to Underweight at KeyBanc
As previously reported, KeyBanc analyst Todd Thomas downgraded Tanger Factory to Underweight from Sector Weight, with a $19 price target, as conditions appear to be deteriorating at an accelerated rate across its pure-play outlet center portfolio.
IIIV i3 Verticals
$25.26

0.74 (3.02%)

10/24/18
DADA
10/24/18
INITIATION
Target $26
DADA
Buy
i3 Verticals initiated with a Buy at DA Davidson
DA Davidson analyst Peter Heckmann initiated i3 Verticals with a Buy rating and a price target of $26, saying the company is "positioned to generate strong growth in revenue and earnings by further penetrating the market for integrated payment and software solutions". The analyst expects i3 Verticals to continue to engage in "accretive acquisitions" and also generate organic growth. Heckmann is also positive on the company's management bringing a "proven track record of building profitable enterprises in the payments space through acquisitions" along with its solid balance sheet and growing free cash flows.
07/16/18
RAJA
07/16/18
INITIATION
Target $19
RAJA
Outperform
i3 Verticals initiated with an Outperform at Raymond James
Raymond James analyst John Davis initiated i3 Verticals with an Outperform rating and $19 price target.
07/16/18
COWN
07/16/18
INITIATION
Target $20
COWN
Outperform
i3 Verticals initiated with an Outperform at Cowen
Cowen analyst George Mihalos initiated i3 Verticals with an Outperform rating as he sees it leveraging its technology in a narrow set of verticals. Mihalos, who set a $20 price target on i3 Verticals, sees the company augmenting a high single digit organic revenue growth rate with an aggressive M&A strategy.
12/11/18
BTIG
12/11/18
INITIATION
Target $27
BTIG
Buy
i3 Verticals initiated with a Buy at BTIG
BTIG analyst Mark Palmer initiated i3 Verticals with a Buy rating and a price target of $27. The analyst cites the company's focus on "attractive payment verticals" in its acquisitions since 2012 within the "large and growing" markets of education, non-profit, public sector, property management and healthcare. Palmer sees i3 Verticals faced with less competition in these markets and expects it to continue generating business wins based on its "ability to tailor embedded payment capabilities to the market-specific needs of its clients".
LPI Laredo Petroleum
$3.79

0.155 (4.27%)

12/19/18
FBCO
12/19/18
DOWNGRADE
FBCO
Underperform
Laredo Petroleum downgraded to Underperform from Neutral at Credit Suisse
12/19/18
FBCO
12/19/18
DOWNGRADE
Target $4
FBCO
Underperform
Laredo Petroleum downgraded to Underperform from Neutral at Credit Suisse
Credit Suisse analyst William Featherston downgraded Laredo Petroleum to Underperform from Neutral and cut his price target for the shares to $4 from $8. The analyst believes Laredo is "structurally challenged" in a low oil price environment and "depressed" Waha gas price environment. The company will struggle to generate oil production growth while spending within cash flow at strip prices, Featherston tells investors in a research note. He sees Laredo as "hampered by sub-par cash generation" given its gassy, high oil decline acreage in the eastern part of the Midland Basin.
12/20/18
SOCO
12/20/18
DOWNGRADE
SOCO
Underweight
Laredo Petroleum downgraded to Underweight from Overweight at Capital One
01/09/19
PIPR
01/09/19
DOWNGRADE
Target $3
PIPR
Neutral
Laredo Petroleum downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Kashy Harrison downgraded Laredo Petroleum to Neutral and lowered his price target for the shares to $3 from $9.
ASGN ASGN
$66.79

1.84 (2.83%)

10/23/18
BOFA
10/23/18
INITIATION
Target $84
BOFA
Buy
ASGN reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Gary Bisbee reinstated coverage on ASGN with a Buy and $84 price target saying it is a best idea in the Business and Information Services sector. The analyst said the pullback in shares provides an opportunity to buy this leading staffer with its US and IT focus. Bisbee said ASGN's quality assets and focus in the fastest growth areas of staffing will drive earnings growth and re-rate shares higher.
10/25/18
WELS
10/25/18
NO CHANGE
Target $82
WELS
Outperform
ASGN price target lowered to $82 from $96 at Wells Fargo
Wells Fargo analyst Edward Caso lowered his price target for ASGN to $82 from $96 entirely due to the recent market multiple correction. The analyst reiterates an Outperform rating on the shares and notes that the company reported "very strong" quarterly results.
08/10/18
FBCO
08/10/18
INITIATION
Target $92
FBCO
Neutral
ASGN initiated with a Neutral at Credit Suisse
Credit Suisse analyst Kevin McVeigh initiated the Business and Professional Services sector, starting ASGN with a Neutral rating and $92 price target, telling investors that ASGN is the highest quality company in his staffing coverage given its growth in excess of already healthy end markets and value creating acquisitions. Additionally, he says ASGN's 2022 targets "look reasonable" and that organic growth in the high-single digit range is "likely sustainable," but these drivers are appropriate captured in valuation.
12/28/18
FBCO
12/28/18
NO CHANGE
Target $62
FBCO
Neutral
ASGN price target cut to $62 from $78 at Credit Suisse
Credit Suisse analyst Kevin McVeigh lowered his price target for ASGN to $62 from $78, citing high leverage and a late cycle.
AIG AIG
$44.18

0.38 (0.87%)

02/05/19
FBCO
02/05/19
INITIATION
Target $46
FBCO
Neutral
AIG initiated with a Neutral at Credit Suisse
Credit Suisse analyst Andrew Kligerman started coverage of AIG with a Neutral rating and $46 price target. The analyst notes that AIG targets a ROE of 8% in 2019 and double-digits within 3 years, but there are numerous headwinds. Further, he points out that AIG faces commercial challenges in General Insurance while yield pressure and reversion likely to affect L&R.
01/22/19
DBAB
01/22/19
NO CHANGE
DBAB
Buy
Deutsche Bank closes short-term idea on AIG
Deutsche Bank analyst Joshua Shanker closed his short-term "Catalyst Call" on AIG while keeping a Buy rating on the shares. The analyst still believes the company's Q4 results on February 6 represent a "positive catalyst." He thinks the results will show progress toward management's goal of delivering an underwriting profit for Q1 and fiscal 2019.
02/05/19
02/05/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. AIG (AIG) initiated with a Neutral at Credit Suisse. 2. Box (BOX) initiated with a Buy at Goldman Sachs. 3. Rocket Pharmaceuticals (RCKT) initiated with an Outperform at Oppenheimer. 4. AstraZeneca (AZN) initiated with an Outperform at Exane BNP Paribas. 5. MercadoLibre (MELI) resumed with a Buy at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/15/19
COMP
01/15/19
INITIATION
Target $44
COMP
Neutral
AIG initiated with a Neutral at Compass Point
Compass Point analyst Bijan Moazami initiated AIG with a Neutral and $44 price target. Moazami said AIG is now an overcapitalized entity with significant expense disadvantages, and generates volatile earnings and carries liabilities on the balance sheet that "no-one can trust yet."
MGM MGM Resorts
$29.23

0.37 (1.28%)

12/05/18
UBSW
12/05/18
NO CHANGE
UBSW
UBS now sees Macau gross gaming revenue declining in 2019
UBS analyst Robin Farley lowered her 2019 Macau gross gaming revenue forecast to down 1% from up 5% previously. Her 2020 GGR estimate is now up 4% from a prior estimate of up 8%. Despite better than expected revenue in November, likely due to hold fluctuations, the lower estimates are driven by weaker VIP and premium demand amid heightened risk to the macroeconomic outlook in China, Farley tells investors in a research note partially titled "More Visitors Spending Less." She raised her price target for Neutral-rated Wynn Resorts (WYNN) to $113 from $108 while lowering her targets for Neutral-rated MGM Resorts (MGM) to $30 from $32 and Neutral-rated Melco Resorts & Entertainment (MLCO) to $19.50 from $21.60. The analyst also keeps a Neutral rating on Las Vegas Sands (LVS).
01/03/19
DBAB
01/03/19
NO CHANGE
Target $33
DBAB
Hold
MGM plan to reduce costs positive for shares, says Deutsche Bank
Deutsche Bank analyst Carlo Santarelli says MGM Resorts this morning announced an "enhanced" margin strategy with a plan to reduce costs and improve efficiencies. He views the "MGM 2020" plan as positive for the shares. The analyst has a Hold rating on MGM with a $33 price target.
01/08/19
JPMS
01/08/19
NO CHANGE
Target $38
JPMS
Overweight
MGM Resorts added to Analyst Focus List at JPMorgan
JPMorgan analyst Joseph Greff added MGM Resorts to his firm's Analyst Focus List saying he sees an increasingly favorable setup for 2019. The analyst raised his price target for the shares to $38 from $35 and keeps an Overweight rating on the name. He sees a combination of relatively low expectations in Las Vegas, improving operations/efficiencies and an attractive valuation.
01/18/19
MSCO
01/18/19
NO CHANGE
MSCO
Overweight
Morgan Stanley prefers Las Vegas to Macau in gaming entering 2019
Morgan Stanley analyst Thomas Allen said he is confident that the Las Vegas outlook is better than perceived after Q4 appears to have shown a meaningful rebound, noting also that his convention tracker supports strong 2019 demand growth and that flight capacity to the market is growing. Meanwhile, as a firm, Morgan Stanley has cut its Macau market gaming revenue outlook and industry view, Allen noted. Combining his Las Vegas outlook and bullish stance on regional U.S. gaming, Allen called MGM Resorts (MGM) and Caesars (CZR) his preferred large cap gaming stocks entering 2019, stating that he believes expectations for both are beatable. He reiterates Overweight ratings on both, as well as on Las Vegas Sands (LVS), and keeps an Equal Weight rating on Wynn Resorts (WYNN).
NUS Nu Skin
$69.58

0.985 (1.44%)

11/21/18
TIGR
11/21/18
NO CHANGE
TIGR
Strong Buy
Nu Skin pullback a buying opportunity, says Tigress Financial
Tigress Financial analyst Ivan Feinseth said he views the recent pullback in shares of Nu Skin as a buying opportunity, citing his belief that the company will continue to benefit from the growing global trend of entrepreneurialism and the global aging population. He reiterates his Strong Buy rating on Nu Skin shares.
10/09/18
DADA
10/09/18
INITIATION
Target $92
DADA
Buy
Nu Skin initiated with a Buy at DA Davidson
DA Davidson analyst Linda Bolton Weiser initiated Nu Skin (NUS) with a Buy rating and a price target of $92, forecasting a 13% organic sales growth and 24% earnings growth in FY18. The analyst notes the achievements of the company's new CEO and CFO in shifting its focus to customer acquisition through "engaging Platforms that leverage social selling, enabling Products that are demonstrable online, and empowering programs to optimize sales performance." Weiser also points to Nu Skin's attractive valuation at 9.0-times her expected FY19 EBITDA - a discount to Herbalife (HLF) and USANA (USNA) which trade around 11-times.
12/12/18
DADA
12/12/18
NO CHANGE
Target $88
DADA
Buy
Nu Skin price target lowered to $88 from $92 at DA Davidson
DA Davidson analyst Linda Bolton Weiser lowered her price target on Nu Skin to $88 after meeting with its CFO Mark Lawrence in a Holiday Beauty Bus Tour. The analyst states that while he was upbeat about the company's 3-pillar growth strategy around "Platforms, Products, and Programs", her lower price target is driven by the assumption of lower 2019 gross margins as the company's "lower margin manufacturing operations are likely to grow faster than the overall business". Weiser also lowers her FY19 EPS view by 15c to $4.00 but maintains a Buy rating on Nu Skin shares longer term on expectations that the company will gradually phase out its "limited time offers", thereby reducing the lumpiness of its sales growth rate.
10/10/18
10/10/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Take-Two (TTWO) initiated with an Outperform at Bernstein. 2. Shake Shack (SHAK) initiated with a Hold at Stifel. 3. Nu Skin (NUS) initiated with a Buy at DA Davidson. 4. Micron (MU) initiated with a Neutral at Piper Jaffray. 5. Crispr Therapeutics (CRSP) initiated with an Outperform at Wells Fargo. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
WMB Williams
$27.02

0.28 (1.05%)

01/16/19
LEHM
01/16/19
UPGRADE
Target $31
LEHM
Overweight
Williams upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Christine Cho upgraded Williams Companies to Overweight with a $31 price target. The company is now positioned to reduce leverage at an accelerated pace and internally fund incremental growth projects and/or return capital to shareholders in a more meaningful way, Cho tells investors in a research note.
01/16/19
01/16/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. MetLife (MET) upgraded to Buy from Neutral at BofA/Merrill with analyst Jay Cohen saying quality concerns are diminishing as management addresses past issues and believes the business mix has notably changed for the positive following the Brighthouse spin. 2. ING Group (ING) upgraded to Buy from Hold at Societe Generale. 3. Williams (WMB) upgraded to Overweight from Equal Weight at Barclays analyst Christine Cho saying the company is now positioned to reduce leverage at an accelerated pace and internally fund incremental growth projects and/or return capital to shareholders in a more meaningful way. 4. Accenture (ACN) upgraded to Buy from Neutral at Citi with analyst Ashwin Shirvaikar saying against a backdrop of rising political and policy risks, a more defensive Information Technology Services stance is appropriate. 5. Nutanix (NTNX) and Teradata (TDC) were upgraded to Overweight from Equal Weight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/28/19
JEFF
01/28/19
DOWNGRADE
JEFF
Hold
DCP Midstream downgraded to Hold from Buy at Jefferies
Jefferies analyst Christopher Sighinolfi downgraded DCP Midstream (DCP) to Hold, from Buy, citing valuation following early year-to-date gains. While he is still bullish on U.S. Midstream, he favors defensive names with contracted 2019-20 cash flow growth supported by pending asset in-services, such as Williams (WMB), Equitrans Midstream (ETRN) and Enterprise Products (EPD), Sighinolfi tells investors.
02/05/19
EVER
02/05/19
INITIATION
Target $31
EVER
Outperform
Williams initiated with an Outperform at Evercore ISI
Evercore ISI analyst Durgesh Chopra initiated Williams with an Outperform and $31 price target.
PS Pluralsight
$31.59

-0.29 (-0.91%)

11/28/18
BARD
11/28/18
INITIATION
Target $28
BARD
Outperform
Pluralsight initiated with an Outperform at Baird
Baird initiated Pluralsight with an Outperform and $28 price target.
11/28/18
BARD
11/28/18
INITIATION
Target $28
BARD
Outperform
Pluralsight initiated with an Outperform at Baird
Baird analyst Jeffrey Meuler initiated Pluralsight with an Outperform rating and a price target of $28, saying the company is "extremely well positioned" to capture a "massive, growing, and underserved" market opportunity. The analyst believes that the management is correct in aggressively investing in the sales and go-to-market capabilities. Meuller is also positive in the company's "cost-effective content development" with added benefits from "scale and network effects". The analyst sees Pluralsight sustainably growing its revenues and billings by 30% or more.
11/29/18
11/29/18
INITIATION

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Pluralsight (PS) initiated with an Outperform at Baird. 2. Expedia (EXPE) initiated with a Market Perform at Telsey Advisory. 3. Energy Transfer LP (ET) initiated with a Buy at Citi. 4. Skyline (SKY) initiated with a Neutral at Credit Suisse. 5. CBS (CBS) and Viacom (VIAB, VIA) were reinstated with a Neutral at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/25/18
JPMS
10/25/18
NO CHANGE
Target $40
JPMS
Overweight
Pluralsight results can lift shares even in 'rough' market, says JPMorgan
Pluralsight's sales productivity "has hit an inflection point" and deals are coming in on higher price points, driving "exceptional" business-to-business again in Q3 with billings growth over 50%, JPMorgan analyst Sterling Auty tells investors in a post-earnings research note. He sees the set-up for the December quarter "offering a similar upside opportunity." And with cash flow turning positive, Pluralsight shares "can get a lift even in this rough market," contends Auty. He keeps an Overweight rating on the stock while trimming his price target to $40 from $44.
SVMK SurveyMonkey
$14.04

-0.05 (-0.35%)

10/22/18
10/22/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Domino's Pizza (DPZ) initiated with a Neutral at UBS. 2. Arco Platform (ARCE) initiated with an Overweight at Morgan Stanley, an Outperform at Itau BBA, and a Buy at Goldman Sachs. 3. Arvinas (ARVN) initiated with a Neutral at Goldman Sachs and an Overweight at Piper Jaffray. 4. Ra Medical Systems (RMED) initiated with a Buy at SunTrust as well as an Overweight at Cantor Fitzgerald and Piper Jaffray. 5. SurveyMonkey (SVMK) initiated with a Buy at SunTrust and BofA/Merrill, an Overweight at JPMorgan, and a Neutral at Credit Suisse and UBS. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/13/18
WELS
11/13/18
INITIATION
Target $13
WELS
Market Perform
SurveyMonkey initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Ivy Cong started SurveyMonkey with a Market Perform rating and $13 price target. As an established category leader from an efficient self-serve revenue model to a growth story driven by expanding enterprise sales, SurveyMonkey makes for a compelling investment case, he contends. However, the analyst believes that these factors are adequately priced into the current share price, especially considering the company's below-average revenue growth versus SaaS peers.
10/22/18
RHCO
10/22/18
INITIATION
Target $16
RHCO
Buy
SurveyMonkey initiated with a Buy at SunTrust
SunTrust analyst Youssef Squali initiated SurveyMonkey (SVMK) with a Buy rating and a price target of $16, saying the company is "effectively leveraging its brand, 'freemium' product, large registered user base and infrastructure to sustainably grow revenues double digits". The analyst expects the company to gain market share in the intelligence business while also citing the visibility of its cash flows from its subscription-based business model. Squali sees further opportunity for growth for SurveyMonkey coming from its enterprise upsell initiative and partnership with Salesforce (CRM).
10/22/18
FBCO
10/22/18
INITIATION
Target $13
FBCO
Neutral
SurveyMonkey initiated with a Neutral at Credit Suisse
Credit Suisse analyst Stephen Ju started SurveyMonkey with a Neutral rating and $13 price target. Given SurveyMonkey's core proposition is to help businesses gather external and internal data to make more informed strategic decisions, the analyst believes it remains a valuable and critical asset. Furthermore, following its investments in 2017 to upgrade its product suite for enterprise consumption, Ju believes it is at only the initial stages of a harvest cycle. That said, with the stock currently trading within 10% of his target price, the analyst is on the sidelines waiting for a more favorable entry point.
H Hyatt
$73.44

3.14 (4.47%)

01/08/19
RAJA
01/08/19
DOWNGRADE
RAJA
Market Perform
Hyatt downgraded to Market Perform from Outperform at Raymond James
01/07/19
01/07/19
DOWNGRADE
Target $75

Neutral
Hyatt downgraded to Neutral from Buy at BofA/Merrill
As previously reported, BofA/Merrill downgraded Hyatt to Neutral from Buy and cut its price target to $75 from $83. Analyst Shaun Kelley is "lukewarm" on Hyatt's recent Two Roads acquisition saying there could be further contract risk if Hyatt doesn't execute carefully. Further, the departure of CFO Pat Grismer also shuts the door of a strong outsider advocate for the transition to a capital light business, the analyst wrote i a note to investors.
01/07/19
BOFA
01/07/19
DOWNGRADE
BOFA
Neutral
Hyatt downgraded to Neutral from Buy at BofA/Merrill
01/08/19
01/08/19
DOWNGRADE

Market Perform
Hyatt downgraded to Market Perform on more cautious macro view at Raymond James
As previously reported, Raymond James downgraded Hyatt to Market Perform from Outperform. Analyst William Crow said he is taking a more defensive stance towards the broader markets and expectations for a slowing US and global economic backdrop. The analyst said Hyatt's transition has come in "fits and starts," and expects asset sales to slow significantly in 2019.

TODAY'S FREE FLY STORIES

TEX

Terex

$35.29

-0.3 (-0.84%)

19:01
02/22/19
02/22
19:01
02/22/19
19:01
Hot Stocks
Terex to sell Demag Mobile Cranes business to Tadano for $215M enterprise value »

Terex announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

CZR

Caesars

$9.05

-0.37 (-3.93%)

18:34
02/22/19
02/22
18:34
02/22/19
18:34
Hot Stocks
Canyon Partners: Caesars shareholders' value best served by open sale process »

Canyon Partners issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERJ

Embraer

$20.85

0.17 (0.82%)

, BA

Boeing

$424.05

6.57 (1.57%)

18:11
02/22/19
02/22
18:11
02/22/19
18:11
Periodicals
Brazilian judge suspends Embraer-Boeing deal talks, Reuters reports »

A Brazilian judge…

ERJ

Embraer

$20.85

0.17 (0.82%)

BA

Boeing

$424.05

6.57 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 11

    Mar

  • 14

    Mar

  • 28

    May

BXG

Bluegreen Vacations

$14.47

0.55 (3.95%)

18:02
02/22/19
02/22
18:02
02/22/19
18:02
Earnings
Bluegreen Vacations reports Q4 EPS 27c, consensus 24c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

SM

SM Energy

$16.88

-0.13 (-0.76%)

17:57
02/22/19
02/22
17:57
02/22/19
17:57
Recommendations
SM Energy analyst commentary at MUFG »

SM Energy's higher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AN

AutoNation

$37.22

-1.15 (-3.00%)

17:47
02/22/19
02/22
17:47
02/22/19
17:47
Syndicate
Breaking Syndicate news story on AutoNation »

AutoNation files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 27

    Feb

TSLA

Tesla

$294.60

3.42 (1.17%)

, NSANY

Nissan

$0.00

(0.00%)

17:42
02/22/19
02/22
17:42
02/22/19
17:42
Periodicals
Tesla's Model 3 was the highest-selling EV globally in 2018, Verge reports »

Tesla's (TSLA) Model…

TSLA

Tesla

$294.60

3.42 (1.17%)

NSANY

Nissan

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 18

    Mar

  • 19

    Mar

FSFG

First Savings Financial Group

$51.33

0.22 (0.43%)

17:31
02/22/19
02/22
17:31
02/22/19
17:31
Hot Stocks
First Savings Financial raises quarterly dividend to 16c per share from 15c »

The dividend will be paid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$110.97

1.5 (1.37%)

17:31
02/22/19
02/22
17:31
02/22/19
17:31
Periodicals
Employees demand Microsoft cancel $480M U.S. Army contract, Reuters says »

Several Microsoft workers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 01

    Mar

  • 03

    Mar

  • 04

    Mar

  • 06

    Mar

  • 07

    Mar

  • 18

    Mar

ENT

Global Eagle

$2.66

(0.00%)

17:23
02/22/19
02/22
17:23
02/22/19
17:23
Hot Stocks
Global Eagle to cut workforce by roughly 15% »

As previously disclosed,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

17:15
02/22/19
02/22
17:15
02/22/19
17:15
General news
Breaking General news story  »

New York Federal Reserve…

NOC

Northrop Grumman

$288.84

2.54 (0.89%)

17:13
02/22/19
02/22
17:13
02/22/19
17:13
Hot Stocks
Northrop Grumman exec Kalan sells 4,312 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYB

LyondellBasell

$89.14

0.63 (0.71%)

17:07
02/22/19
02/22
17:07
02/22/19
17:07
Syndicate
Breaking Syndicate news story on LyondellBasell »

LyondellBasell files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCCO

Technical Comm Corp

$2.76

0.17 (6.56%)

17:06
02/22/19
02/22
17:06
02/22/19
17:06
Hot Stocks
Technical Comm Corp to submit plan to regain compliance with Nasdaq by March 4 »

Technical Comm Corp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFU

InfuSystem

$4.15

0.04 (0.97%)

17:01
02/22/19
02/22
17:01
02/22/19
17:01
Hot Stocks
InfuSystem announces settlement of derivative lawsuit »

InfuSystem Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALU

Kaiser Aluminum

$108.22

-1.9 (-1.73%)

17:01
02/22/19
02/22
17:01
02/22/19
17:01
Hot Stocks
Kaiser Aluminum names Neal West as new CFO »

Kaiser Aluminum announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDR

Alder Biopharmaceuticals

$14.35

0.19 (1.34%)

17:00
02/22/19
02/22
17:00
02/22/19
17:00
Hot Stocks
Alder Biopharmaceuticals submits eptinezumab BLA to FDA »

Alder BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

RF

Regions Financial

$16.24

-0.01 (-0.06%)

16:59
02/22/19
02/22
16:59
02/22/19
16:59
Syndicate
Breaking Syndicate news story on Regions Financial »

Regions Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

HL

Hecla Mining

$2.59

-0.145 (-5.31%)

16:58
02/22/19
02/22
16:58
02/22/19
16:58
Syndicate
Breaking Syndicate news story on Hecla Mining »

Hecla Mining files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$50.99

0.84 (1.68%)

, CELG

Celgene

$89.15

0.54 (0.61%)

16:52
02/22/19
02/22
16:52
02/22/19
16:52
Hot Stocks
Bristol-Myers files proxy statement in connection with proposed Celgene merger »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$50.99

0.84 (1.68%)

CELG

Celgene

$89.15

0.54 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 28

    Feb

  • 18

    May

  • 20

    May

  • 28

    May

TEN

Tenneco

$36.29

0.76 (2.14%)

16:48
02/22/19
02/22
16:48
02/22/19
16:48
Earnings
Tenneco sees FY19 revenue growth up 4%-5%, consensus $4.65B »

The company expects 2019…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

TEN

Tenneco

$36.29

0.76 (2.14%)

16:46
02/22/19
02/22
16:46
02/22/19
16:46
Earnings
Tenneco reports preliminary Q4 revenue $4.3B, consensus $4.3B »

Sees FY18 EPS "near…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

XRX

Xerox

$31.50

0.16 (0.51%)

16:44
02/22/19
02/22
16:44
02/22/19
16:44
Conference/Events
Xerox management to meet with Loop Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

TWTR

Twitter

$31.70

0.94 (3.06%)

16:38
02/22/19
02/22
16:38
02/22/19
16:38
Hot Stocks
Twitter board member Evan Williams to step down at end of month »

On February 22, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

ALLY

Ally Financial

$26.95

-0.07 (-0.26%)

16:34
02/22/19
02/22
16:34
02/22/19
16:34
Hot Stocks
Ally Financial CEO sells over 97,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Mar

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.